Graham J, Earnshaw S, Lim J, Luthra R, Borker R. Cost-effectiveness of afatinib versus erlotinib in the first-line treatment of patients with metastatic non-small cell lung cancer with EGFR Exon 19 deletion mutations. JCP. 2016 May;2(4):31-9.
Garcia-Esteve L, Navarro P, Ascaso C, Torres A, Aguado J, Gelabert E, Martin-Santos R. Family caregiver role and premenstrual syndrome as associated factors for postnatal depression. Arch Womens Ment Health. 2008 Jul;11(3):193-200.